Dechra Pharmaceuticals PLC
$46.71
24H
Market Cap
Volume
Supply
Price Chart
About Dechra Pharmaceuticals PLC - DPH.L
Dechra Pharmaceuticals PLC is an international pharmaceutical company focused on developing, manufacturing, and marketing veterinary products, including a range of therapies and diets for pets and livestock. The company, with a strong presence in Europe, North America, and other international markets, is known for providing a broad spectrum of pharmaceuticals and related products for veterinary use.
What are Dechra Pharmaceuticals PLC's core values and mission statement?
Dechra Pharmaceuticals PLC focuses on veterinary pharmaceuticals and related products, with core values centered on commitment to the veterinary profession, providing high quality products and services, and working collaboratively to ensure the wellbeing of animals. Their mission is to be leaders in their chosen markets by providing veterinary professionals with solutions that improve the lives of animals.
Who founded Dechra Pharmaceuticals PLC and when?
Dechra Pharmaceuticals PLC was founded in 1997 as a result of a management buy-out from Lloyds Chemists.
Who leads Dechra Pharmaceuticals PLC?
As of the last update before my knowledge was cut off, Dechra Pharmaceuticals PLC was led by Ian Page, who served as the Chief Executive Officer.
Where is Dechra Pharmaceuticals PLC located, and what is its base country?
Dechra Pharmaceuticals PLC is located in Northwich, Cheshire, England, and its base country is the United Kingdom.
On which exchanges is Dechra Pharmaceuticals PLC traded?
Dechra Pharmaceuticals PLC is listed on the London Stock Exchange (LSE).
Historical data
Dechra Pharmaceuticals PLC (DPH) Price Live Data
The live price of Dechra Pharmaceuticals PLC (DPH) is $46.71, with a trading volume of 192,108 in the last 24 hours. Wrapstocks updates the DPH price in real-time. Dechra Pharmaceuticals PLC is up 0.05% in the last 24 hours. The company has a live market cap of $53,208,771.49 and a supply of 1,139,060 DPH stocks.
Dechra Pharmaceuticals PLC (DPH) is traded on London Stock Exchange, and currently, the market is closed; trading will be resumed in 17 hours and 48 minutes.
